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Objective. To determine if douching with Water Works device for 1 month can (1) lower or eliminate perceived vaginal odor by
subject; (2) have any eﬀects on vaginal ecosystem. Methods. Ten women with perceived vaginal odor with or without discharge,
douchedeverydayfor4weeksinanopen-label,nonrandomizedpilotstudy.Primaryoutcomemeasuresincludedperceivedvaginal
odor by subject, lactobacilli score from Nugent slide, and acceptance of the Water Works douching system. Secondary outcome
included the safety of using this douching device. Results. At week 4, there was improvement in vaginal odor (P = .0006) and
there was no signiﬁcant change in lactobacilli score. Conclusion. Douching with Water Works device is associated with reduction
or elimination of vaginal odor without adversely aﬀecting the vaginal ecosystem.
Copyright © 2006 Ashwin J. Chatwani et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
Vaginal symptoms, including abnormal odor with or with-
out complaints of discharge, are relatively common com-
plaints for gynecologic consultation [1]. The evaluation of
vaginal complaints is based primarily on the diagnosis of
bacterial vaginosis (BV), trichomoniasis, and vaginal can-
didiasis (VVC) [2, 3]. Healthy women may experience vagi-
naldischarge.Thequantityofdischargeappearstovaryfrom
woman to woman and during an individual woman’s men-
strual cycle. Normal vaginal ﬂuid may have an odor that
can be unpleasant [4]. Although BV is the most prevalent
cause of vaginal discharge or malodor [5], studies in a va-
riety of settings have demonstrated that neither BV nor any
pathogenic microbe can be found in approximately a third
of symptomatic women [6, 7]. The presence or absence of
a microbe corresponds poorly with the presence or absence
of symptoms. Clinicians are often faced with symptoms for
which there are no obvious cause.
Douching has been reported with a variety of adverse
outcomes[8–13].Studiessuggestthattheeﬀectsofdouching
are modulated by the products used for douching [10, 11,
13],thereason,timinginrelationtosexualactivityandmen-
strual cycle [10, 11, 14]. A variety of commercial and home-
made products are used for diﬀerent reasons [15, 16]. The
determinants of douching behavior are poorly understood
even though it is widely practiced by many women in the
United States [14, 17]. Although the question to douche or
not to douche is still being debated [18, 19], possible beneﬁts
of douching are also suggested [13, 20].
Anecdotal evidence suggests that stainless steel has an ef-
fect in reducing odors and is so used to reduce odors on
hands by chefs. Water Works is a medical grade, light weight
(1oz) stainless steel douching device that was developed to
aid in thetreatmentof vaginalinfections. Apilot clinical trial
of subjects with BV using a stainless steel device showed po-
tential for reducing and even eliminating vaginal odor. There
is no known treatment for vaginal odor of nonbacterial ori-
gin. In addition pharmaceutical interventions are not appro-
priate in the face of the inability to identify a cause of odor.
Purpose of our study was to evaluate whether douching with
WaterWorksdeviceispotentiallybeneﬁcialforthetreatment2 Infectious Diseases in Obstetrics and Gynecology
of abnormal vaginal odor while maintaining a normal vagi-
nal ecosystem.
MATERIALS AND METHODS
This open-label, nonrandomized pilot study was conducted
at the Gynecology Clinic of Temple University Hospital. The
study protocol was approved by the Temple University In-
stitutional Review Board. Females attending the clinic who
complainedofabnormalvaginalodorwerescreenedforvagi-
nal infection. If clinical examination did not reveal any infec-
tion, the subject was invited to participate in the study. Ma-
jor inclusion criteria included: (1) age 18 years and older; (2)
complaint of abnormal odor with or without complaints of
discharge, (3) odor scale 3 or greater (on a scale of 0–5, ﬁve
being theworst);(4)subjectnottreatedforBV,VVCwithin-
travaginal, oral antifungal medications or antibiotics, within
the last 14 days of enrollment. Exclusion criteria included:
(1) pregnancy; (2) under treatment for cervical neoplasia;
(3)abnormalanatomyorpathologyofthevagina;(4)known
HIV positive; (5) currently menstruating; (6) external factor
(s) producing the odor and (6) body mass index (BMI) of 33
or greater.
STUDY DESIGN
Women who met eligibility criteria were asked to participate
in the study. Informed consent was obtained. All subjects
were treated for a total of 4 weeks. Each patient underwent
entryvisit,2ndvisitaftertwoweeksofdouchingand3rdvisit
after 4 weeks of douching.
CLINICAL METHODS DURING ENTRY VISIT
Standardized history and information on present genital
symptoms, pregnancy history, contraceptive status and prior
vaginitis history was taken. Same physician examined each
patient and results were recorded on a standard form. Pa-
tient perceived vaginal odor scores were recorded. The vagi-
nal pH was measured and vaginal swabs were collected from
theposteriorandlateralvaginalfornicesinallpatients.Saline
wet mount and 10% KOH microscopy of vaginal secretions
as well as Amine (“whiﬀ”) test were performed. Papanico-
laou (Pap) smear were done when results were not avail-
able or collected within 12 months. Gram stains for Nugent
score slides were sent to a central laboratory to maintain
the uniformity of the readings. Pregnancy test (urine HCG),
OSOM Trichomonas rapid test or Trichomonas vaginalis cul-
ture (in subjects with a negative wet mount for trichomon-
ads), Chlamydia trachomatis DNA test, Neisseria gonorrhoeae
DNA test were done. Herpes simplex virus culture was done
only if suspected. Vaginal yeast culture was done on all sub-
jects.
INVESTIGATIONAL PRODUCT
Water Works device is made of medical grade stainless steel.
The kit includes a customized water container and tubing.
It is a gravity-fed douching device, listed with the FDA
that is Class I (21 CFR 884.5900). 32 ounces tepid tap wa-
ter was used as douching ﬂuid. Water container was hung
approximately 3 feet above the vagina (eye level). It was de-
signed to give a water pressure around 15mm of mercury.
Total douching time was approximately 2min with constant
manipulation of the douching device to make contact with
all of the vaginal walls.
TREATMENT REGIMEN
All subjects were instructed on how to use the treatment
device and asked to douche once daily with the exception
of the days of evaluation and menstruation. They were re-
frained from the use of other douches and intravaginal prod-
ucts (eg, feminine deodorant sprays, spermicides, tampons,
and diaphragms) during the 4-week study period. They were
notallowedtotakeoral/intravaginalantibioticsorantifungal
agents during the 4-week study periods. Each subject kept
a brief diary where they recorded their own assessment of
vaginal odor and other vaginal symptoms during the whole
length of study period. During 2nd and 3rd visits the specu-
lumexaminationofthevaginawererepeated.Swabsforvagi-
nal pH, whiﬀ test, saline and 10% KOH microscopy, were
taken. Gram stain for Nugent score was sent to the central
laboratory. Perceived vaginal odor score by the subjects were
recorded.
SAMPLE SIZE AND STATISTICAL ANALYSIS
This is a pilot study designed to estimate potential eﬀect sizes
sowecanmorereliablyestimatesamplesizerequirementsfor
arandomized,controlledtrial.Basedupondatafrom10sub-
jects, simple descriptive statistics were calculated. We used
Student’s t-test for continuous, paired variables.
RESULTS
We screened 50 symptomatic women who were examined
by the same gynecologist at Temple University Hospital, De-
partment of OB/GYN between May 2005 and September
2005. Ten subjects met criteria and were enrolled for this pi-
lot study. All the enrolled patients were African American.
The mean age of the participants was 37.3
￿ 10.15 (mean
￿
standard deviation) years.
Atthescreeningvisit(Entryvisit),allwomencomplained
ofstrongvaginalodor.Themeanvaginalodorscorewas4.4
￿
0.3 (range 0–5). This odor was signiﬁcantly reduced (P =
.016) after 2 weeks of vaginal douching to 2.4
￿ 0.6( m e a n
￿
standard error). Odor score was further reduced to 1.7
￿ 0.6
(P = .0006) after 4 weeks of douching (Figure 1). Five out
of 10 subjects perceived complete abatement of odor at the
end of study. Lactobacilli score from the Nugent slide was
4.0
￿ 0( m e a n
￿ standard error) on entry visit, and showed
no signiﬁcant decrease during 2nd (3.3
￿0.3) and 3rd (3.5
￿
0.4) visits (Figure 2). Mean vaginal pH was 4 at both entry
visit and ﬁnal visit. At the end of treatment no statistically
signiﬁcant change of vaginal pH was noted.Ashwin J. Chatwani et al 3
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Figure 1:Perceivedvaginalodorscoredfromthevisualanalogscale
by subjects shows signiﬁcant reduction (
￿P = .016) on 2nd visit
with further reduction (
￿
￿P<. 0006) on 3rd visit. Data presented
as mean
￿ standard error, n = 10.
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Figure 2: Lactobacilli score from the Nugent slide at entry, 2nd and
4th visit showed no signiﬁcant (P>. 05) decrease from baseline
during 2nd and 3rd visit. Data expressed as mean
￿ standard error,
n = 10.
Acceptability of the douching by the subjects was very
high; one developed asymptomatic BV detected by Nugent
score. All the subjects completed the study.
DISCUSSION
The results of the present study, performed in 10 subjects
with perceived vaginal odor with no infectious cause of
vaginitis, conﬁrm the eﬃcacy and safety of the douching
once daily for 4 weeks. At the ﬁrst follow-up visit after 2
weeks of vaginal douching the perceived vaginal odor was
40% reduced. The second follow-up visit after 4 weeks of
treatment further conﬁrmed the eﬀectiveness of douching by
reducing the odor by 59% of baseline value. Half of the sub-
jects showed complete recovery of their complaint of vagi-
nal odor. Lactobacilli are the predominant bacteria in nor-
m a lv a g i n a lﬂ o r a[ 21]. They maintain an acidic environment
(pH of 4.5 or less in normal vagina), considered to be one
of the protective mechanisms of the vagina [22]. Several in
vitro and in vivo experiments in humans have examined
how douching aﬀects vaginal pH and microﬂora [18, 23].
Douching may wash away lactobacilli and protective factors
and weaken the defense system in the vaginal ecology. In
our study, douching induced no negative modiﬁcation of the
vaginal ﬂora, as observed by lactobacilli score from Nugent
slidesandvaginalpHdetermination.Althoughdouchinghas
not been recommended for frequent use, previous study of
daily douching caused no signiﬁcant alterations in vaginal
pH, which is in support of our ﬁnding [24]. BV is likely to
occurwhenthebalancebetweenprotectiveorganismandpo-
tential pathogens is adversely altered.
Intensity and methods of douching, especially douching
with pressure, have been associated with adverse outcomes.
Therefore, the risk of ascending infection from the pressure
of douching may be greatest around the time of ovulation
when the cervical os is gaping and the mucus is thin. Recent
study did not support the relation between douching and
either gonococcal/chlamydial genital infection or pelvic in-
ﬂammatory diseases [25]. The Water Works douching device
isdesignedsothatthewaterisdirecteddownwardawayfrom
the cervical os and also it is gravity fed to avoid the ascending
infection. We did not observe any symptoms of pelvic infec-
tion during the length of study.
There are several limitations to our study. Vaginal dis-
charge and odor were self-reported by participants, and at
present, there are no validated instruments for objective as-
sessment of vaginal symptoms. The size of small study popu-
lation is our other limitation, but examination of all patients
by the same physician and reading of slides for Nugent score
by the same person at a central laboratory are the strengths
of our study. Because this was a nonblinded study, there is
the potential of reporting bias by both the clinician and the
subject. Finally we did not attempt to follow up the patients
to determine long-term eﬀect of frequent douching.
Our ﬁndings suggest that further study of douching in
a randomized, controlled trial is warranted. Future studies
should also optimize the length and frequency of treatment.
Nonetheless, our data suggest that the Water Works Douch-
ingDeviceisbeneﬁcialforthetreatmentofvaginalodorwith
no objective ﬁndings of vaginal infection while maintaining
a normal vaginal ecosystem.
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